External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: A randomized comparison of monophasic and biphasic shock energy application

European Heart Journal

Volumn 28, Issue 14, 2007, Pages 1731-1738

  Manegold, Johannes C ^a   Israel, Carsten W ^a   Ehrlich, Joachim R ^a   Duray, Gabor ^a   Pajitnev, Dmitri ^a   Wegener, Florian T ^a   Hohnloser, Stefan H ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Atrial fibrillation; Biphasic shocks; Cardioversion; Implantable cardioverter defibrillator; Monophasic shocks; Pacemaker

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS GLYCOSIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; IMPEDANCE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WAVEFORM;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; EQUIPMENT FAILURE ANALYSIS; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 34547791825     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm211     Document Type: Article

References (24)

1. Israel CW, Neubauer H, Olbrich HG, Hartung W, Treusch S, Hohnloser SH. Incidence of Atrial tachyarrhythmias in pacemaker patients: results from the balanced evaluation of atrial tachyarrhythmias in stimulated patients (BEATS) study. Pacing Clin Electrophysiol 2006;29:582-588.
2. Wilkoff BL, Hess M, Young J, Abraham WT. Differences in tachyarrhythmia detection and implantable cardioverter defibrillatior therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004;15:1002-1009.
3. Giedwoyn JO. Pacemaker failure following external defibrillation. Circulation 1971;44:293.
4. Aylward P, Blood R, Tonkin A. Complications of defibrillation with permanent pacemaker in situ. Pacing Clin Electrophysiol 1979;2:462-464.
5. Das G, Eaton J. Pacemaker malfunction following transthoracic countershock. Pacing Clin Electrophysiol 1981;4:487-490.
6. Gould L, Patel S, Gomes GI, Chokshi AB. Pacemaker failure following external defibrillation. Pacing Clin Electrophysiol 1981;4:575- 577.
7. Levine PA, Barold SS, Fletcher RD, Talbot P. Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol 1983;1:1413-1422.
8. Waller C, Callies F, Langenfeld H. Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes: is external cardioversion contraindicated in patients with permanent pacing systems? Europace 2004;6:165-168.
9. Lau FYK, Bilitch M, Wintroub HJ. Protection of implanted pacemakers from excessive electrical energy of DC shock. Am J Cardiol 1969;23:244-249.
10. Das G, Staffanson DB. Selective dysfunction of ventricular electrode-endocardial junction following DC cardioversion in a patient with dual chamber pacemaker. Pacing Clin Electrophysiol 1997;20:364-365.
11. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary. Circulation 2006;114:700-752.
12. Stellbrink C, Nixdorff U, Hofmann T, Lehmacher W, Daniel WG, Hanrath P, Geller C, Mügge A, Sehnert W, Schmidt-Lucke C. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation. Circulation 2004;109:997-1003.
13. Kirchhof P, Eckhardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Böcker D, Breithardt G, Haverkamp W, Borggrefe M. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 2002;360:1275-1279.
14. Joglar JA, Hamdan MH, Ramaswamy K, Zagrodzky JD, Sheehan CJ, Nelson LL, Andrews TC, Page RL. Initial energy for elective external cardioversion of persistent atrial fibrillation. Am J Cardiol 2000;86:348-350.
15. Barold SS, Falkoff MD, Ong LS, Heinle RA. Interference in cardiac pacemakers: exogenous sources. In: El-Sherif N, Samet P, eds. Cardiac Pacing and Electrophysiology. Philadelphia, WB: Saunders; 1991. p608-633.
16. Levine PA. Effect of cardioversion and defibrillation on implanted cardiac pacemakers. In: Barold SS, ed. Modern Cardiac Pacing. Mount Kisco, NY: Futura Publ. Co.; 1985. p875-886. NY.
17. Altamura G, Bianconi L, Lo Bianco F, Toscano L, Ammirati F, Pandozi C, Castro C, Cardinale M, Mennuni M, Santini M. Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol 1995;18:194-198.
18. Botto GL, Politi A, Bonini W, Broffoni T, Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart 1999;82:726-730.
19. Mittal S, Ayati S, Stein KM, Schwartzman D, Cavlovich D, Tchou PJ, Markowitz SM, Slotwiner DJ, Scheiner MA, Lerman BB. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000;101:1282-1287.
20. Page RL, Kerber RE, Russell JK, Trouton T, Waktare J, Gallik D, Olgin JE, Ricard P, Dalzell GW, Reddy R, Lazzara R, Lee K, Carlson M, Halperin B, Bardy GH. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, doubleblind multicenter trial. J Am Coll Cardiol 2002;39:1956-1963.
21. Israel CW, Ehrlich JR, Barold SS, Hohnloser SH. Treatment of atrial tachyarrhythmias with pacing and antiarrhythmic drugs. In: Israel CW, Barold SS, eds. Advances in the Treatment of Atrial Tachyarrhythmia. Pacing, Cardioversion and Defibrillation. Armonk, NY: Futura Publishing Co. Inc.; 2002. p305-323.
22. Jung W, Manz M, Pizulli L, Pfeiffer D, Lüderitz B. Effects of chronic amiodarone therapy on defibrillation threshold. Am J Cardiol 1992;70:1023-1027.
23. Pelosi F Jr, Oral H, Kim MH, Sticherling C, Horwood I, Knight BP, Michaud GF, Morady F, Strickberger SA. Effects of chronic amiodarone therapy on defibrillation energy requirements in humans. J Cardiovasc Electrophysiol 2000;11:736-740.
24. Hohnloser SH, Dorian P, Roberts R, Gent M, Israel CW, Fain E, Champagne J, Connolly SJ. Effect of amiodarone and sotalol on ventricular defibrillation threshold. The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial. Circulation 2006;114:104-109.